Trials / Unknown
UnknownNCT00642044
Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Universidade Federal do Rio de Janeiro · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
Cross-linking of the cornea increases the mechanical and biochemical stability of the stromal tissue. The purpose of this study is to assess the effectiveness of riboflavin-ultraviolet light induced cross-linking of corneal collagen in improving visual acuity and reducing progression of keratoconus in the Brazilian population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Corneal Collagen Crosslinking | UV light and Riboflavin eyedrops every 5 minutes for 30 minutes. |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2008-12-01
- Completion
- 2009-12-01
- First posted
- 2008-03-24
- Last updated
- 2008-04-23
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00642044. Inclusion in this directory is not an endorsement.